Pharvaris (PHVS) Competitors $24.15 -0.72 (-2.90%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends PHVS vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ARAV, ACABW, ACABU, and BFRIWShould you be buying Pharvaris stock or one of its competitors? The main competitors of Pharvaris include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry. Pharvaris vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Alvotech Aravive Atlantic Coastal Acquisition Corp. II Atlantic Coastal Acquisition Corp. II Biofrontera 180 Life Sciences (NASDAQ:ATNFW) and Pharvaris (NASDAQ:PHVS) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, dividends, community ranking, institutional ownership, risk, valuation, analyst recommendations and earnings. Do analysts rate ATNFW or PHVS? Pharvaris has a consensus price target of $33.60, suggesting a potential upside of 39.13%. Given Pharvaris' higher possible upside, analysts plainly believe Pharvaris is more favorable than 180 Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 180 Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/APharvaris 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60 Which has stronger earnings & valuation, ATNFW or PHVS? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/APharvarisN/AN/A-$109.18M-$2.58-9.36 Does the media refer more to ATNFW or PHVS? In the previous week, Pharvaris had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for Pharvaris and 0 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 0.00 equaled Pharvaris'average media sentiment score. Company Overall Sentiment 180 Life Sciences Neutral Pharvaris Neutral Does the MarketBeat Community favor ATNFW or PHVS? Pharvaris received 35 more outperform votes than 180 Life Sciences when rated by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/APharvarisOutperform Votes3566.04% Underperform Votes1833.96% Is ATNFW or PHVS more profitable? 180 Life Sciences' return on equity of 0.00% beat Pharvaris' return on equity.Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Pharvaris N/A -37.09%-35.13% SummaryPharvaris beats 180 Life Sciences on 4 of the 6 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Pharvaris News Delivered to You Automatically Sign up to receive the latest news and ratings for PHVS and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PHVS vs. The Competition Export to ExcelMetricPharvarisPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$7.03B$5.40B$8.53BDividend YieldN/A7.96%5.13%4.14%P/E Ratio-9.369.93115.5615.18Price / SalesN/A381.421,484.3492.77Price / CashN/A47.3439.6634.07Price / Book4.895.324.665.02Net Income-$109.18M$153.56M$119.06M$225.46M7 Day Performance11.24%0.11%0.80%0.37%1 Month Performance31.82%15.22%5.65%3.57%1 Year Performance40.57%41.14%36.76%29.44% Pharvaris Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PHVSPharvaris2.058 of 5 stars$24.15-2.9%$33.60+39.1%+42.8%$0.00N/A-9.3630Upcoming EarningsATNFW180 Life SciencesN/A$0.01flatN/A-9.1%$0.00N/A0.007Positive NewsLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.05+28.6%N/AN/A$0.00N/A0.002Gap UpAIMDWAinosN/A$0.03flatN/AN/A$0.00$65,122.000.0040ALVOWAlvotechN/A$3.20+5.3%N/AN/A$0.00$306.77M0.004Positive NewsALVOAlvotech2.0875 of 5 stars$13.02+0.3%$18.00+38.2%+51.6%$0.00$93.38M-4.911,026ARAVAravive0.8692 of 5 stars$0.04flatN/AN/A$0.00$9.14M-0.0420High Trading VolumeACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03flatN/AN/A$0.00N/A0.004ACABUAtlantic Coastal Acquisition Corp. IIN/A$12.54flatN/A+19.1%$0.00N/A0.004Positive NewsGap UpBFRIWBiofronteraN/A$0.07-64.6%N/A+119.3%$0.00$35.24M0.0070Gap DownHigh Trading Volume Related Companies and Tools Related Companies 180 Life Sciences Alternatives 4D pharma Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Alvotech Alternatives Aravive Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Biofrontera Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PHVS) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharvaris Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharvaris With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
